PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-10.57%
Both yoy net incomes decline, with MCHP at -2.24%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
113.04%
Some yoy growth while MCHP is negative at -3.20%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
75.47%
SBC growth well above MCHP's 5.42%. Michael Burry would flag major dilution risk vs. competitor’s approach.
173.20%
Slight usage while MCHP is negative at -122.26%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
121.57%
AR growth is negative or stable vs. MCHP's 267.34%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
126.19%
Some inventory rise while MCHP is negative at -213.79%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
260.95%
Some yoy usage while MCHP is negative at -129.39%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-105.88%
Negative yoy while MCHP is 335.67%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
80.35%
Some CFO growth while MCHP is negative at -12.30%. John Neff would note a short-term liquidity lead over the competitor.
30.07%
Some CapEx rise while MCHP is negative at -7.36%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
5.13%
Less growth in investment purchases vs. MCHP's 86.33%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
199.82%
We have some liquidation growth while MCHP is negative at -60.52%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
-762.87%
We reduce yoy invests while MCHP stands at 117.88%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
65.68%
Debt repayment growth of 65.68% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-81.67%
Negative yoy issuance while MCHP is 94.38%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
0.44%
Buyback growth of 0.44% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.